Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-12 09:50 am Purchase | 13G | Allakos Inc. ALLK | FMR LLC | 5,370,247 6.044% | 3,954,777 (+279.40%) | View |
2024-07-08 4:32 pm Sale | 13G | Allakos Inc. ALLK | BlackRock Inc. BLK | 1,267,129 1.400% | -3,848,959 (-75.23%) | View |
2024-02-14 4:58 pm Sale | 13G | Allakos Inc. ALLK | CITADEL ADVISORS LLC | 3,304,622 3.800% | -1,462,307 (-30.68%) | View |
2024-02-14 4:01 pm Sale | 13G | Allakos Inc. ALLK | Logos Global Management LP | 2,900,000 3.300% | -2,386,666 (-45.15%) | View |
2024-02-14 08:34 am Sale | 13G | Allakos Inc. ALLK | Deep Track Capital LP | 2,510,736 2.870% | -2,489,264 (-49.79%) | View |
2024-02-12 10:07 am Sale | 13G | Allakos Inc. ALLK | PRICE T ROWE ASSOCIATES INC | 638,102 0.700% | -7,282,606 (-91.94%) | View |
2024-02-12 10:03 am Purchase | 13G | Allakos Inc. ALLK | PRICE T ROWE ASSOCIATES INC | 7,920,708 9.100% | 7,920,708 (New Position) | View |
2024-02-02 12:31 pm Sale | 13D | Allakos Inc. ALLK | RiverVest Venture Fund III L.P. | 108,159 0.200% | -4,848,743 (-97.82%) | View |
2024-01-29 5:25 pm Purchase | 13G | Allakos Inc. ALLK | BlackRock Inc. BLK | 5,116,088 5.800% | 2,430,687 (+90.51%) | View |
2024-01-26 4:20 pm Purchase | 13G | Allakos Inc. ALLK | Deep Track Capital LP | 5,000,000 5.720% | 2,489,264 (+99.14%) | View |
2024-01-26 09:21 am Sale | 13G | Allakos Inc. ALLK | Deep Track Capital LP | 2,510,736 2.870% | -2,388,443 (-48.75%) | View |
2024-01-18 4:32 pm Purchase | 13G | Allakos Inc. ALLK | BIOTECHNOLOGY VALUE FUND L P | 16,552,417 18.900% | 8,000,000 (+93.54%) | View |
2024-01-18 4:29 pm Purchase | 13G | Allakos Inc. ALLK | BIOTECHNOLOGY VALUE FUND L P | 8,552,417 9.800% | 3,545,496 (+70.81%) | View |
2023-10-13 4:50 pm Purchase | 13G | Allakos Inc. ALLK | CITADEL ADVISORS LLC | 4,766,929 5.500% | 4,766,929 (New Position) | View |
2023-08-18 5:10 pm Sale | 13D | Allakos Inc. ALLK | Alta Partners VIII L.P. | 3,037,955 3.500% | -5,634,482 (-64.97%) | View |
2023-04-17 5:29 pm Sale | 13G | Allakos Inc. ALLK | Frazier Life Sciences Public Fund L.P. | 392,269 0.500% | -4,399,731 (-91.81%) | View |
2023-02-14 4:23 pm Sale | 13G | Allakos Inc. ALLK | Logos Global Management LP | 5,286,666 6.200% | -650,000 (-10.95%) | View |
2023-02-14 11:58 am Purchase | 13G | Allakos Inc. ALLK | Frazier Life Sciences Public Fund L.P. | 4,792,000 5.600% | 1,892,000 (+65.24%) | View |
2023-02-14 08:24 am Purchase | 13G | Allakos Inc. ALLK | Deep Track Capital LP | 4,899,179 5.750% | 380,604 (+8.42%) | View |
2023-02-09 11:07 am Sale | 13G | Allakos Inc. ALLK | VANGUARD GROUP INC | 2,952,522 3.470% | -542,152 (-15.51%) | View |